View in EDS

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

Saved in:
Bibliographic Details
Title: EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
Authors: Gillmore, Roopinder1, Stuart, Sam2, Kirkwood, Amy3, Hameeduddin, Ayshea2, Woodward, Nick2, Burroughs, Andrew K.4, Meyer, Tim1,5 t.meyer@ucl.ac.uk
Source: Journal of Hepatology. Dec2011, Vol. 55 Issue 6, p1309-1316. 8p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first